Recent Press Releases

SANOFI ANNOUNCES TOP-LINE RESULTS FOR CARDIOVASCULAR OUTCOMES STUDY OF LYXUMIA® (LIXISENATIDE)

- Results support resubmission of U.S. New Drug Application in Q3 2015 - Mar 19, 2015 PARIS, March 19, 2015 /PRNewswire/ -- Sanofi announced today top-line results of the Phase IIIb ELIXA...

ASTRAZENECA AND DAIICHI SANKYO TO JOINTLY COMMERCIALISE MOVANTIK IN THE US

AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc. for MOVANTIK™ (naloxegol) in the US, in line with the Company's strategy of delivering value through...

Help Protect Texas' Babies: Make sure your children are fully vaccinated

NEW YORK, March 18, 2015 /PRNewswire/ --  A new bilingual, online resource is now available for parents

Indian generic companies should reject Gilead's controversial hepatitis C 'Anti-Diversion' programme

Indian generic companies should reject Gilead's controversial hepatitis C 'Anti-Diversion' programme Programme could compromise patient treatment and privacy rights MSF releases briefing...

Johnson & Johnson Announces Strategic Investment Alliance to Combat Dementia Globally

NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced tha

Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology

Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking Session

THOUSAND OAKS, Cali

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference

Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States

FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015

Sandoz to Pay $12.64 Million in CMP Settlement with HHS OIG for Misrepresenting Drug Pricing Data to Medicare

Washington, DC - The HHS Office of Inspector General (OIG) announced today that Sandoz Inc. will pay $12.64 million to settle allegations it misrepresented drug pricing data to the Medicare program....

MD Anderson News Release: MD Anderson study predicts new hepatitis C drugs will place a dramatic financial strain on the health care system

HOUSTON ­­– The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country's...

Actavis Completes Allergan Acquisition

- Combination Creates One of the Fastest Growing, Most Dynamic Pharmaceutical Companies in Global Healthcare - - Leading Positions in Eye Care, Neurosciences/CNS, Medical...

Phase 3 Study with IMBRUVICA® (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression

Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small...

Shantha will provide up to 37 million doses of Shan5(TM)

- Shan5(TM) pentavalent pediatric vaccine will protect children against 5 pediatric diseases - Lyon, France - March 17, 2015 - Sanofi Pasteur, the vaccines division of Sanofi, announced today that...

KYTHERA Biopharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Over-Allotment Option

WESTLAKE VILLAGE, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the closing of its underwritten public offering of 2,994,793 shares of its...

European Commission Clears Actavis' Pending Acquisition of Allergan

DUBLIN and IRVINE, Calif., March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) ("Actavis") and Allergan, Inc. (NYSE: AGN) ("Allergan") today announced that the companies...

Endo Withdraws Proposal For Salix

Company Focused on Moving Forward with its Growth Strategies and Active Pipeline of Acquisition Targets Endo International plc ENDP, +1.91% (ENL) today confirmed that it is withdrawing its cash and...

Valeant and Salix Agree on Amended Terms to Merger Agreement

$173 Per Share Cash Offer Through April 7TH Transaction Expected to Close April 1ST LAVAL, Quebec & RALEIGH, N.C.--(BUSINESS WIRE)-- Valeant Pharmaceuticals International, Inc. (VRX)...

Treatment for chronic painful bowel condition to get NHS funding approval

Treatment for chronic painful bowel condition to get NHS funding approval A drug to treat a long-term and often distressing bowel condition is being recommended for routine NHS funding by the...

Mylan Launches First and Only Available Intermediate Dosage Strengths of Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr

POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr,...

99 Percent of Commenters Agree: FDA Proposed Guidance Is a Bad Idea, Undermines Purpose of FDA and Puts Patients at Risk

Draft Guidance Would Let Pharmaceutical Industry Tell Doctors Its Products Are Safer Than FDA Has Deemed Them WASHINGTON, D.C. – Ninety-nine percent of people or organizations that commented on...